[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100559915":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":25,"responsibleParty":35,"collaborators":25,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":25,"eligibilityCriteria":45,"healthyVolunteers":46,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":25,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":25,"overallStatus":59,"whyStopped":25,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":25},{"fullName":5,"class":6},"Seoul National University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Fentanyl-Morphine","EXPERIMENTAL","Spinal anesthesia with heavy bupivacaine, fentanyl and morphine",[13],"Drug: Fentanyl-Morphine",{"label":15,"type":16,"description":17,"interventionNames":18},"Morphine","ACTIVE_COMPARATOR","Spinal anesthesia with heavy bupivacaine and morphine",[19],"Drug: Morphine",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Intrathecal injection of bupivacaine, fentanyl and morphine",[9],null,{"type":22,"name":15,"description":27,"armGroupLabels":28,"otherNames":25},"Intrathecal injection of bupivacaine and morphine",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Jin-Tae Kim, M.D., Ph.D","CONTACT","+82-2-2072-2467","jintae73@gmail.com",{"type":36,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Jin-Tae Kim","Professor","100559915","phase-4-analgesic-efficacy-of-intrathecal-fentanyl-morphine-combination-versus-morphine-alone-for-intraoperative-pain-during-elective-cesarean-delivery-100559915",false,"NCT06570343","Analgesic Efficacy of Intrathecal Fentanyl-Morphine Combination Versus Morphine Alone for Intraoperative Pain During Elective Cesarean Delivery","Analgesic Efficacy of Intrathecal Fentanyl-Morphine Combination Versus Morphine Alone for Intraoperative Pain During Elective Cesarean Delivery: a Randomized Clinical Trial","Inclusion Criteria:\n\n* Parturients of gestational age \\> 37 weeks, scheduled for cesarean section under spinal anesthesia\n\nExclusion Criteria:\n\n* Contraindication to spinal anesthesia\n* Any sign of onset of labor\n* Emergency cesarean section\n* Body weight \\\u003C 40 kg or \\> 120 kg\n* Height \\\u003C 140 cm or \\> 190 cm\n* Severe underlying cardiovascular disease\n* Known fetal anomaly\n* Preeclampsia\n* History of hypersensitivity to fentanyl or morphine\n* Chronic opioid use",true,"FEMALE","19 Years","99 Years",{"count":51,"type":52},186,"ESTIMATED","INTERVENTIONAL",[55],"PHASE4","Pregnant women scheduled for elective cesarean sections under spinal anesthesia are randomly assigned to two groups: 1) the Fentanyl-Morphine (FM) group, and 2) the Morphine (M) group. In addition to 11.5 mg of bupivacaine, the FM group receives 15 μg of fentanyl and 50 μg of morphine intrathecally, while the M group receives 50 μg of morphine intrathecally. The incidence of intraoperative pain with a Numerical Rating Scale (NRS) score of 4 or higher is compared between the two groups to evaluate the analgesic effects of combined intrathecal fentanyl-morphine therapy versus morphine alone.",[58],"Intraoperative Pain","NOT_YET_RECRUITING","2024-09-29",{"date":62,"type":63},"2024-10-01","ACTUAL",{"date":65,"type":52},"2024-09-20",{"date":67,"type":52},"2025-12-25",{"name":5,"class":6}]